Effect of levamisole on metabolism of phagocytic cells.
The effect of levamisole (LMS) on glucose metabolism was studied using a protozoan phagocytic model and human leukocytes. At concentrations of greater than 10 microgram/ml, LMS inhibited glucose metabolism in the protozoan phagocytic model. Glucose metabolism in both the phagocytic model and normal peripheral blood leukocytes was, however, minimally altered when exposed to levels of LMS of less than 10 microgram/ml. In contrast, myeloblasts from a child with leukemia seemed to have increased metabolic activity and 5 microgram/ml of LMS markedly reduced the glucose metabolism. These preliminary studies suggest that LMS can alter glucose metabolism of certain cells and that some malignant cells may be directly inhibited metabolically by LMS.
D002648:Child; D005947:Glucose / Q000378:metabolism*; D006801:Humans; D066298:In Vitro Techniques; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy / Q000378:metabolism; D007962:Leukocytes / Q000187:drug effects / Q000378:metabolism; D007978:Levamisole / Q000494:pharmacology*; D008297:Male; D008954:Models, Biological; D010586:Phagocytes / Q000187:drug effects* / Q000378:metabolism; D013769:Tetrahymena pyriformis / Q000187:drug effects / Q000378:metabolism
D007978:Levamisole; D005947:Glucose